CCR5 and cancer: However, in many types of cancer, tumor epithelial cells can develop pathological expression of CCR5, induced upon oncogenic transformation, which allows them to hijack the migratory phenotype of immune cells, inducing a homing behaviour towards metastatic sites [105,109].